N@N

Market Maker Surveillance Report. GSS, AVEO, ATV, EJ, ATHX, CTIX, Winning Stocks With Lowest Price Friction For Monday, Decemb

^{Published on 2012-12-24 18:01:04 - WOPRAI}
 

December 24, 2012 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Monday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Monday there were 4032 companies with "abnormal" market making, 2155 companies with positive Friction Factors and 2838 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Monday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. GOLDEN STAR RESOURCES LTD (AMEX:GSS), Aveo Pharmaceuticals Inc (NASDAQ:AVEO), Alto Ventures Ltd (NYSE:ATV), E-House (China) Holdings Ltd (NYSE:EJ), Athersys Inc (NASDAQ:ATHX), Cellceutix Corp (OTC:CTIX). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

  Symbol  Change    Percent   Buy Volume   Buy %%    Sell Volume  Sell %%   Net Volume   Friction
  GSS     $0.250    16.45%    1,554,633    42.13%    904,769      24.52%    649,864      25,995  
  AVEO    $0.830    12.79%    340,708      60.72%    220,168      39.24%    120,540      1,452   
  ATV     $0.430    19.45%    36,537       33.72%    34,303       31.65%    2,234        52      
  EJ      $0.520    14.29%    268,913      47.38%    164,194      28.93%    104,719      2,014   
  ATHX    $0.330    31.43%    142,962      68.44%    65,918       31.56%    77,044       2,335   
  CTIX    $0.340    18.09%    741,200      44.41%    565,877      33.90%    175,323      5,157   

For example, the chart above shows GSS with a dollar gain Monday of $0.25000 and a Friction Factor of 25,995 shares. That means that it only took 25,995 more shares of buying than selling to move GSS higher by one penny. The Market Makers are currently allowing the stock to rise quickly (low friction). The combination of low friction and positive market direction can drive prices higher much faster than normal.

GOLDEN STAR RESOURCES LTD (AMEX:GSS) - Golden Star Resources Ltd., a gold mining and exploration company, through its subsidiaries, engages in the exploration and production of gold. Its principal properties include 90% interest in the Bogoso/Prestea mine having mining and exploration concessions covering a strike length of approximately 85 kilometers located along the Ashanti Trend in southwest Ghana; and 90% interest in the Wassa gold mine located in the southwestern region of Ghana. Golden Star also has an 81% interest in the Prestea Underground mine situated in Ghana. In addition, it holds interests in several gold exploration projects in Ghana and elsewhere in West Africa, including Sierra Leone, Burkina Faso, Niger, and Cte dIvoire, as well as holds and manages exploration properties in Brazil in South America. The company was founded in 1984 and is based in Littleton, Colorado..

Aveo Pharmaceuticals Inc (NASDAQ:AVEO) - AVEO Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of cancer therapeutics. The companys lead product candidate, Tivozanib (AV-951), is a novel, highly potent and selective oral inhibitor of the vascular endothelial growth factor, or VEGF, receptors 1, 2, and 3. It is also leading the clinical development of AV-299, which includes conducting multiple Phase I clinical trials and preparing for the conduct of multiple Phase II clinical trials. The companys product candidate in preclinical development is AV-203, a potent ErbB3 antibody that has demonstrated efficacy in vivo. It has strategic partnerships with OSI Pharmaceuticals, Inc., Merck, and Biogen Idec, Inc. AVEO Pharmaceuticals was formerly known as GenPath Pharmaceuticals, Inc. and changed its name to AVEO Pharmaceuticals, Inc. in March 2005. The company was founded in 2001 and is based in Cambridge, Massachusetts..

Alto Ventures Ltd (NYSE:ATV) - Acorn International, Inc., an integrated multi-platform marketing company, operates TV direct sales businesses and a nationwide off-TV distribution network. Its TV direct sales platform consists of airtime purchased from national and local channels. Acorn also offers consumer products and services through catalogs, third-party bank channels, and outbound telemarketing centers, as well as through an e-commerce Website. The company was founded in 1998 and is headquartered in Shanghai, the Peoples Republic of China..

E-House (China) Holdings Ltd (NYSE:EJ) - E-House (China) Holdings Limited, through its subsidiaries, operates as a real estate services company in China. It provides primary real estate agency services, secondary real estate brokerage services, real estate information and consulting services, real estate advertising services, real estate online services, and real estate investment fund management services. The company offers primary real estate agency services to real estate developers of residential properties. Its secondary real estate brokerage services include offering advisory services on choices of properties; accompanying potential buyers on house viewing trips; drafting purchase contracts; negotiating price and other terms; and providing preliminary proof of title, as well as coordinating with the notary, the bank, and the title transfer agency. The company also provides market information to buyers and sellers based on its research, as well as listing and brokerage services comprising sales and rentals. Its real estate consulting services include land acquisition consulting and land development consulting. The companys real estate information services comprise the sale of online subscriptions to its proprietary CRIC system to support its primary and secondary real estate agency services. Its real estate advertising services comprise advertising design and sales in print and other media. The companys real estate online services include real estate news, information, property data, and access to online communities to real estate consumers and participants through local Web sites. Its real estate investment fund management activities consist of investments in Chinas real estate sector. E-House (China) Holdings Limited was founded in 2000 and is headquartered in Shanghai, the Peoples Republic of China..

Athersys Inc (NASDAQ:ATHX) - Athersys, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutic products in various disease areas in the United States. Its product pipeline includes MultiStem, a novel allogeneic approach to stem cell therapy and regenerative medicine for treating a range of diseases. The company also develops orally active pharmaceutical products for the treatment of obesity and certain central nervous system disorders, including narcolepsy, excessive daytime sleepiness, and chronic fatigue, as well as other potential indications consisting of attention deficit hyperactivity disorder and other cognitive disorders, including schizophrenia. It has product co-development collaboration with Angiotech Pharmaceuticals, Inc. for the potential application of MultiStem in multiple cardiovascular indications, including myocardial infarction, peripheral vascular disease, and certain other indications. In addition, the company has a collaboration agreement with Pfizer Inc. to develop and commercialize MutiStem for the treatment of inflammatory bowel disease. Athersys, Inc. was founded in 1995 and is based in Cleveland, Ohio..

Cellceutix Corp (OTC:CTIX) - Cellceutix Corporation, a development stage biopharmaceutical company, develops cancer and anti-inflammatory drugs in the United States. The companys lead product candidate includes Kevetrin, which is in pre-clinical development stage primarily for the treatment of head and neck cancers. It is also developing various other product candidates for the treatment of psoriasis, rheumatoid arthritis, osteo-arthritis/asthma, and hypertensive emergency, as well as neurological disorders, such as multiple sclerosis, Lou Gehrig disease, and/or Parkinson's disease. The company was founded in 2007 and is headquartered in Beverly, Massachusetts..

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net